Group One Trading
AVIR icon

Group One Trading’s Atea Pharmaceuticals AVIR Stock Holding History

Group One Trading’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,017,300
Closed -$2.95M – 8115
2025
Q3 		$2.95M Buy
+1,017,300
New +$3.47M 0.01% 1947
2025
Q2 		– Sell
-500
Closed -$1.5K – 7925
2025
Q1 		$1.5K Buy
500
+200
+67% +$624 ﹤0.01% 7087
2024
Q4 		$1K Sell
300
-407,400
-100% -$1.35M ﹤0.01% 6885
2024
Q3 		$1.37M Sell
407,700
-431,400
-51% -$1.56M ﹤0.01% 2043
2024
Q2 		$2.78M Buy
839,100
+4,800
+0.6% +$17.9K 0.01% 1194
2024
Q1 		$3.37M Buy
+834,300
New +$3.27M 0.01% 1106
2023
Q3 		– Sell
-600
Closed -$2.24K – 7631
2023
Q2 		$2.24K Buy
600
+100
+20% +$374 ﹤0.01% 7048
2023
Q1 		$1.68K Buy
+500
New +$2.03K ﹤0.01% 6650
2022
Q4 		– Sell
-1,600
Closed -$9K – 7212
2022
Q3 		$9K Sell
1,600
-200
-11% -$1.53K ﹤0.01% 6539
2022
Q2 		$13K Sell
1,800
-119,900
-99% -$819K ﹤0.01% 6590
2022
Q1 		$879K Sell
121,700
-96,600
-44% -$656K ﹤0.01% 3216
2021
Q4 		$1.95M Buy
218,300
+190,600
+688% +$2.97M ﹤0.01% 2626
2021
Q3 		$971K Buy
27,700
+24,900
+889% +$691K ﹤0.01% 3446
2021
Q2 		$60K Buy
+2,800
New +$84.1K ﹤0.01% 6419

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Group One Trading's AVIR Position: Q2 2026 in Review

Group One Trading increased its Atea Pharmaceuticals (AVIR) stake by 367% in Q2 2026, buying an estimated $547 and bringing the position to 140 shares worth $651. The position accounts for ﹤0.01% of the portfolio, ranked #7250.

Group One Trading first reported a position in AVIR in Q3 2021 and has held it in 13 quarters since. The position peaked at $1.32M in Q4 2021. 125 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Group One Trading held 140 shares of Atea Pharmaceuticals worth $651 as of Q2 2026.
  • Group One Trading bought 110 Atea Pharmaceuticals shares in Q2 2026, an estimated $547.
  • Atea Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7250 holding.
  • Group One Trading first reported a position in Atea Pharmaceuticals in Q3 2021 and has held it in 13 quarters since.
  • Group One Trading's Atea Pharmaceuticals position peaked at $1.32M in Q4 2021.
  • 125 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.